These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20009036)

  • 1. Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture.
    Xu Z; Castellino FJ; Ploplis VA
    Blood; 2010 Mar; 115(10):2038-47. PubMed ID: 20009036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
    Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
    Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
    Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE
    Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosis.
    Ghosh AK; Murphy SB; Kishore R; Vaughan DE
    PLoS One; 2013; 8(5):e63825. PubMed ID: 23724005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte PAI-1 influences the cardiac transcriptome and limits the extent of cardiac fibrosis in response to left ventricular pressure overload.
    Ghosh AK; Kalousdian AA; Shang M; Lux E; Eren M; Keating A; Wilsbacher LD; Vaughan DE
    Cell Signal; 2023 Apr; 104():110555. PubMed ID: 36584735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE
    Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B; Cordasic N; Klanke B; Heusinger-Ribeiro J; Daniel C; Veelken R; Hartner A; Hilgers KF
    J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
    Ma J; Weisberg A; Griffin JP; Vaughan DE; Fogo AB; Brown NJ
    Kidney Int; 2006 Mar; 69(6):1064-72. PubMed ID: 16528256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
    Rabieian R; Boshtam M; Zareei M; Kouhpayeh S; Masoudifar A; Mirzaei H
    J Cell Biochem; 2018 Jan; 119(1):17-27. PubMed ID: 28520219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of insulin receptor substrate-1 signaling induces the cardiovascular and proteo(fibrino)lytic system derangements typical of insulin resistance.
    Furumoto T; Fujii S; Onozuka H; Tarikuz Zaman AK; Goto D; Sugawara T; Mikami T; Watanabe S; Abe K; Terauchi Y; Kadowaki T; Kitabatake A; Sobel BE
    Coron Artery Dis; 2005 Mar; 16(2):117-23. PubMed ID: 15735405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.
    Takeshita K; Hayashi M; Iino S; Kondo T; Inden Y; Iwase M; Kojima T; Hirai M; Ito M; Loskutoff DJ; Saito H; Murohara T; Yamamoto K
    Am J Pathol; 2004 Feb; 164(2):449-56. PubMed ID: 14742251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of plasminogen activator inhibitor may prevent cardiac rupture in female and castrated mice after myocardial infarction.
    Chua S; Wang HL; Lin YC; Wu CH; Tsai TH; Chang LT; Kao YH; Yen CH; Yip HK; Sun CK
    Gend Med; 2011 Aug; 8(4):239-51. PubMed ID: 21664194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPAR-γ is involved in the protective effect of 2,3,4',5-tetrahydroxystilbene-2-O-beta-D-glucoside against cardiac fibrosis in pressure-overloaded rats.
    Peng Y; Zeng Y; Xu J; Huang XL; Zhang W; Xu XL
    Eur J Pharmacol; 2016 Nov; 791():105-114. PubMed ID: 27568841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.